Home6BG • FRA
add
Lytix Biopharma AS
Previous close
€0.75
Day range
€0.76 - €0.76
Year range
€0.37 - €0.93
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (NOK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 24.26M | 4.21% |
Net income | -23.34M | -2.63% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -24.25M | -5.29% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (NOK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 90.00M | 106.77% |
Total assets | 95.46M | 69.61% |
Total liabilities | 17.02M | -12.49% |
Total equity | 78.44M | — |
Shares outstanding | 68.26M | — |
Price to book | 0.66 | — |
Return on assets | -59.00% | — |
Return on capital | -69.89% | — |
Cash Flow
Net change in cash
| (NOK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -23.34M | -2.63% |
Cash from operations | -10.19M | 38.42% |
Cash from investing | -691.00K | -1,059.72% |
Cash from financing | -229.00K | -27.93% |
Net change in cash | -11.11M | 33.29% |
Free cash flow | -1.70M | 79.06% |
About
Founded
2003
Website
Employees
6
